EP
IFRX icon

Eversept Partners’s InflaRx IFRX Stock Holding History

Eversept Partners’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Buy
1,758,573
+1,261
+0.1% +$1.19K 0.08% 94
2025
Q4 		$1.77M Buy
1,757,312
+26,677
+2% +$33.1K 0.09% 89
2025
Q3 		$2.32M Buy
1,730,635
+90,205
+5% +$95.8K 0.16% 65
2025
Q2 		$1.3M Sell
1,640,430
-35,548
-2% -$42K 0.12% 59
2025
Q1 		$1.71M Buy
1,675,978
+1,183,526
+240% +$2.23M 0.17% 47
2024
Q4 		$1.22M Sell
492,452
-1,129,335
-70% -$2.17M 0.11% 61
2024
Q3 		$2.48M Buy
1,621,787
+54,857
+4% +$83.5K 0.17% 56
2024
Q2 		$2.73M Buy
1,566,930
+261,790
+20% +$384K 0.19% 57
2024
Q1 		$2.01M Hold
1,305,140
– – 0.13% 61
2023
Q4 		$2.13M Sell
1,305,140
-432,404
-25% -$741K 0.19% 50
2023
Q3 		$5.18M Sell
1,737,544
-177,569
-9% -$676K 0.44% 40
2023
Q2 		$8.54M Buy
+1,915,113
New +$8.57M 0.71% 31
2021
Q2 		– Sell
-268,634
Closed -$1.05M – 97
2021
Q1 		$1.05M Buy
+268,634
New +$1.38M 0.08% 75
2020
Q2 		– Sell
-195,488
Closed -$747K – 73
2020
Q1 		$747K Sell
195,488
-139,130
-42% -$515K 0.19% 49
2019
Q4 		$1.33M Buy
+334,618
New +$978K 0.23% 59

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return

Eversept Partners's IFRX Position: Q1 2026 in Review

Eversept Partners increased its InflaRx (IFRX) stake by 0.07% in Q1 2026, buying an estimated $1.19K and bringing the position to 1,758,573 shares worth $1.57M. The position accounts for 0.08% of the portfolio, ranked #94.

Eversept Partners first reported a position in IFRX in Q4 2019 and has held it in 15 quarters since. The position peaked at $8.54M in Q2 2023. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • Eversept Partners held 1,758,573 shares of InflaRx worth $1.57M as of Q1 2026.
  • Eversept Partners bought 1,261 InflaRx shares in Q1 2026, an estimated $1.19K.
  • InflaRx made up 0.08% of Eversept Partners's portfolio in Q1 2026, its #94 holding.
  • Eversept Partners first reported a position in InflaRx in Q4 2019 and has held it in 15 quarters since.
  • Eversept Partners's InflaRx position peaked at $8.54M in Q2 2023.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.